Decoy Therapeutics Inc (DCOY)

Jun 09, 2026

Decoy Therapeutics: David Arthur Completing His Service on the Board >DCOY - Moomoo

Jun 09, 2026

Jun 08, 2026

Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London - PR Newswire

Jun 08, 2026

Jun 05, 2026

[RW] Decoy Therapeutics Inc. SEC Filing - Stock Titan

Jun 05, 2026

Jun 04, 2026

DCOY | Decoy Therapeutics Inc. Common Executive Compensation - Quiver Quantitative

Jun 04, 2026

Jun 04, 2026

Decoy Therapeutics (DCOY) details 2026 director, pay and auditor votes - Stock Titan

Jun 04, 2026

Jun 04, 2026

DCOY Q3 2024 Earnings: Narrower-Than-Expected Loss Fails to Offset Investor ConcernsSpecial Dividend Alert - newsline.com

Jun 04, 2026

Jun 03, 2026

Decoy Therapeutics nominates Patricia Gauthier to board - Investing.com UK

Jun 03, 2026

Jun 03, 2026

Decoy Therapeutics nominates Patricia Gauthier to board By Investing.com - Investing.com South Africa

Jun 03, 2026

Jun 03, 2026

Decoy Therapeutics Nominates Global Biopharma Executive Patricia Gauthier for Election to Board of Directors - PR Newswire

Jun 03, 2026

Jun 02, 2026

hVIVO win with Decoy Therapeutics signals shift towards broader contract research market, says broker - Proactive Investors

Jun 02, 2026

Jun 02, 2026

Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAV™ Ca - GuruFocus

Jun 02, 2026

Jun 01, 2026

hVIVO signs consultancy deal with antiviral developer Decoy Therapeutics - Proactive Investors

Jun 01, 2026

Jun 01, 2026

hVIVO to support Decoy Therapeutics respiratory antiviral development - Vox Markets

Jun 01, 2026

Jun 01, 2026

hVIVO signs consultancy deal with Decoy Therapeutics By Investing.com - Investing.com Canada

Jun 01, 2026

Jun 01, 2026

Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAV™ Candidate into the Clinic - Financial Times

Jun 01, 2026

Jun 01, 2026

HVIVO plc Signs Consultancy Contract With Decoy Therapeutics - marketscreener.com

Jun 01, 2026

May 27, 2026

Decoy Therapeutics (DCOY) Surges 10.75%: Is Momentum Building for the Biotech Stock?ATR Stop - The Legal Advocate

May 27, 2026

May 26, 2026

Decoy Therapeutics names MIT professor as advisory board chair - Investing.com

May 26, 2026

May 26, 2026

Decoy Therapeutics names MIT professor as advisory board chair By Investing.com - Investing.com Canada

May 26, 2026

May 26, 2026

Decoy Therapeutics Inc. Announces Appointment of Brad L. Pentelute as Chair of Scientific Advisory Board - marketscreener.com

May 26, 2026

May 23, 2026

Decoy Therapeutics (DCOY) Surges 13.5%: Testing Key Resistance at $7.67Modified Schiff - The Legal Advocate

May 23, 2026

May 22, 2026

Decoy Therapeutics Inc. (DCOY) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

May 22, 2026

May 22, 2026

DCOY Sets May 22 Vote, Puts Focus Back on Thinly Traded Stock - Bez Kabli

May 22, 2026

May 20, 2026

hVIVO to host capital markets day as it pitches broader clinical development role - Yahoo Finance UK

May 20, 2026

May 19, 2026

Decoy Therapeutics Sets 2026 Annual Shareholder Meeting Date - TipRanks

May 19, 2026

May 19, 2026

Decoy Therapeutics sets date for 2026 annual meeting and proposal deadlines - Investing.com Australia

May 19, 2026

May 18, 2026

Number of shareholders of Decoy Therapeutics Inc. – NASDAQ:DCOY - TradingView

May 18, 2026

May 15, 2026

Decoy Therapeutics outlines antiviral pipeline milestones By Investing.com - Investing.com Nigeria

May 15, 2026

May 10, 2026

Certain Restricted Stock Units of Decoy Therapeutics Inc. are subject to a Lock-Up Agreement Ending on 11-MAY-2026. - marketscreener.com

May 10, 2026

May 10, 2026

Certain Stock Options of Decoy Therapeutics Inc. are subject to a Lock-Up Agreement Ending on 11-MAY-2026. - marketscreener.com

May 10, 2026

May 10, 2026

1,051,782 Common Stock of Decoy Therapeutics Inc. are subject to a Lock-Up Agreement Ending on 11-MAY-2026. - marketscreener.com

May 10, 2026

May 09, 2026

Decoy Therapeutics Inc. 2026 Q1 10-Q Filing: Financial Results, Risk Factors, and Forward-Looking Statements - Minichart

May 09, 2026

May 08, 2026

Decoy Therapeutics: Q1 Earnings Snapshot - KTEN

May 08, 2026

May 08, 2026

Decoy Therapeutics Inc. 1Q 2026: Net loss $(2.22M), EPS $(4.18) — 10-Q Summary - TradingView

May 08, 2026

May 08, 2026

Decoy Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 08, 2026

May 07, 2026

DCOY Q1'26 Earnings: EPS estimate is (4.12) USD - TradingView

May 07, 2026

May 02, 2026

Decoy Therapeutics to implement 1-for-12 reverse stock split - Investing.com

May 02, 2026

Apr 27, 2026

Decoy Therapeutics to Present at Two Peptide Therapeutics Conferences in Boston - BioSpace

Apr 27, 2026

Apr 27, 2026

Decoy Therapeutics (DCOY) Proxy Filing Summary - Quartr

Apr 27, 2026

Apr 27, 2026

Decoy Therapeutics Inc (FRA:FP11) Stock PDF (Updated: 2026/04/27) - GuruFocus

Apr 27, 2026

Apr 27, 2026

Decoy Therapeutics Showcases Novel Antiviral Therapies in Boston - Intellectia AI

Apr 27, 2026

Apr 27, 2026

Decoy Therapeutics Inc (FRA:FP11) Stock Earnings Transcripts - GuruFocus

Apr 27, 2026

Apr 26, 2026

Salarius Pharmaceuticals stock tumbles after announcing $7 million discounted public offering - MSN

Apr 26, 2026